Federal contract receipt
$13,721,004 from Department of Health and Human Services to LEIDOS BIOMEDICAL RESEARCH INC
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS
Signals
Full and openLarge awardMulti-year performance
Office of Federal Procurement Policy
Public Spend Intelligence - sledai.com
Award #CONT_AWD_75N91020F00009_7529_75N91019D00024_7529
Signed2024-09-25
PlaceMD
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS
Total obligated$13,721,004.00
PoP Start
2020-04-01
PoP End
2028-07-31
COMPETED
Awarded on 2024-09-25
Vendor
LEIDOS BIOMEDICAL RESEARCH INC
Agency
Department of Health and Human Services
Category
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Place
MD
© 2025 Sled AI Inc. All rights reserved.